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Abstract  
Introduction: HIV is still a major public health challenge, especially in resource-limited settings. In Nigeria, it is estimated that over 50% of those 
infected with HIV do not know their status. With the recent Nigerian governmental approval of a "Test and Start Strategy", we embarked on HIV 
testing and services in four defined locations to mark 2017 World AIDS Day. The aim of this report is to document the process and outcome of the 
exercise. Methods: four teams led by senior clinical associates implemented the services and were mandated to test at least 100 persons per 
location. At each location, we carried out the following activities: (1) short advocacy to community leaders, (2) HIV testing and counselling, (3) 
disclosure of results, post-test counselling and healthy life-style education and (4) distribution of free male condoms and Information, Education 
and Communication (IEC) material. Results: a total of 237 people (male 195, female 42) were tested, the majority of whom were between 19 and 
49 years (93.7%). Two people were found to be positive, giving a 0.84% positivity rate. Informal interactions between service providers and the 
people tested revealed that people were aware of HIV as a public health problem, and people positively received HIV services. Although there is a 
selection bias, as those tested will not be truly representative of the population, the current positively rate of less than 1% is low compared to 
previous Nigerian estimates, which are based on antenatal testing. However, the exercise showed a willingness to be tested and fair knowledge of 
HIV as a problem. Population-based data from across Nigeria should be aggregated to determine community prevalence pending the National 
population-based HIV survey in 2018. Such information will inform evidence-based decisions on the necessity of such large-scale surveys in future 
years. Conclusion: there is an urgent need to define the real prevalence of HIV in Nigeria through a well planned and executed community based 
survey. 
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Introduction 
 
HIV has remained a disease of public health importance since 1981 
when it was identified and characterized [1,2]. To date, HIV has 
claimed more than 35 million lives with over a million people dying 
from HIV-related causes globally. It is estimated that approximately 
36.7 million people are living with HIV by the end of 2016 [3, 4] and 
1.8 million new infections occurred in the same year globally. 
Pregnant women, infants and other vulnerable populations, such as 
prison inmates and men who have sex with men have higher risk of 
acquiring HIV and thus developing AIDS. In Nigeria, the prevalence 
of HIV has previously been determined by antenatal studies. 
Seroprevalence studies among antenatal clinic (ANC) attendees in 
some Nigeria centres have shown variable prevalence rates over the 
years ranging from a nadir of 1.8% (1991) to a peak of 5.8% in 
2001, with a more recent estimate of 3.0% in 2014 [5]. However, 
many have questioned the validity of using ANC studies to estimate 
national prevalence as all ANC attendees are sexually active and the 
majority in Nigeria are in stable relationships. Thus, another study-
the National HIV & AIDS and Reproductive Health Survey (NARHS)-
has been used as an alternative to the ANC seroprevalence studies. 
According to NARHS, the national HIV prevalence rate obtained in 
2013 was 3.4%, lower than the 3.6% reported in 2007 and further 
supporting the declining HIV prevalence reported from ANC studies 
[6]. However, the NARHS sampling and research methodology may 
not provide a reliable estimate of the general population. It is 
estimated that over 50% of those infected with HIV do not know 
their status as HIV testing and counselling in the country is still low. 
According to National Demographic and Health Survey, seven in 10 
women and about 8 in 10 men have never been tested for HIV [7]. 
With the recent approval of Test and Start Strategy by the Federal 
Ministry of Health in Nigeria, to mark 2017 World AIDS Day (WAD) 
with the Theme: MY HEALTH, MY RIGHT [8]; Excellence and 
Friends Management Care Centre (EFMC), with permission and 
support from National Agency for the Control of AIDS (NACA) 
embarked on strategic HIV testing and services in four defined 
locations in Abuja, Federal Capital Territory (FCT) on December 1st, 
2017. The aim of this report is to document the process and 
outcome of the exercise; as well as to review some critical findings. 
  
  
Methods 
 
Excellence and Friends Management Care Centre (EFMC) is one of 
the Nigerian non-governmental organizations partnering with NACA, 
the Nigerian Federal Ministry of Health (FMOH), the United States 
President's Emergency Plan for AIDS Response (PEPFAR) and other 
donors/partners to implement a comprehensive HIV response in 
Nigeria, aimed at eliminating HIV as a diseases of public health 
importance. We obtained approval to implement strategic HIV 
testing and services (HTS) in key locations in Abuja, FCT from 
NACA. NACA also sponsored media activities to sensitise the public 
for HIT testing during the World AIDS Day week in several national 
radio and television channels. EFMC staff and management planned, 
sourced for materials, implemented and reported on a one-day HIV 
Testing Services (HTS) in four different locations within Abuja, FCT 
(Figure 1). Four teams led by senior clinical associates implemented 
the services and were mandated to test at least 100 persons per 
location. We arrived at each location to meet receptive clients who 
were waiting to be tested. Most clients heard about the exercise on 
radio. The four teams were made up of between four to ten EFMC 
staff stationed at Dutse Junction, EFAB Estate, Galadima Junction 
and EFMC Dawaki Office, all in Bwari Area Council, Abuja Nigeria. At 
each location, depending on the nature of the site, we carried out 
the following activities: (1) short advocacy to community leaders, 
(2) HIV testing and counselling, (3) disclosure of results, post-test 
counselling and healthy life-style education and (4) supply of free 
male condoms and Information, Education and Communication 
(IEC) material distribution. An example of an outreach location is 
shown in and HIV testing in Figure 2. Consent was obtained from 
EFMC Board as well as from each client before counselling and 
testing was carried out. Clients confidentiality and privacy were 
maintained as data was anonymized with all identifiers removed 
before recording and analysing. 
  
  
Results 
 
A total of 237 people (male 195, female 42) were tested across the 
four sites, with the majority (42%) tested at the Galadimma bus-
stop (Table 1). The majority (222, 93.7%) of those tested were 
between 19 and 49 years. Two (2) people were found to be 
positive, giving a 0.84% positivity rate (Table 2). Both of those 
reactive were females within the age group 25-49 years. Of the two 
who were reactive, one already knew her status and was re-testing. 
Informal interactions between service providers and the people 
tested revealed that people were aware of HIV as a public health 
problem and people positively received HIV services. 
  
  
Discussion 
 
Although there may be some element of selection bias, as those 
tested may not be truly representative of the population, the current 
positively rate of less than 1% is low compared to previous positivity 
rates. It will be good to compare this positivity rate with the 
positivity rates of other organizations that carried out similar 
exercise in other parts of the region and across the Nigeria. The 
data across the country should also be compiled and aggregated to 
determine the community prevalence pending the implementation of 
the National population-based HIV survey in 2018. It will also be 
useful to compare the findings from the aggregate with the findings 
of the periodic antenatal sentinel and population-based surveys. 
Such comparison will inform evidence based decisions on the 
necessity of such large-scale surveys in future years. Integrating 
this outreach with other healthcare services will both increase 
uptake, acceptability and improve efficiency in the use of resources 
as previously reported [9]. The absence of a truly community-based 
HIV prevalence for Nigeria further justifies the need for a population 
based study as currently proposed by the country [10, 11]. 
However, this resource can also be used to achieve the first 90 of 
the UNAIDS 90-90-90 goals in Nigeria. This may require additional 
funds, but the benefits of such a program will far outweighs the 
additional funds needed to make it happen. Our findings again show 
that more males are willing to access HIV testing than females, but 
still have far lower positivity rate than females. This is slightly 
different to our 6-year report in HIV programming in Nigeria where 
a total of 915, 058 people were tested for HIV between 2011/2012 
and 2016/2017 from our 75 supported delivery sites, out of which 
27,121 were HIV positive with a positivity rate of 3.0%; but only 
38.9% of all those tested were males as shown in Table 3 [12]. 
Recent publication by UNAIDS on December 1,2017 revealed that 
"men are less likely to take an HIV test, less likely to access 
antiretroviral therapy and more likely to die of AIDS-related illnesses 
than women". UNAIDS goes on to say "Globally, less than half of 
men living with HIV are on treatment, compared to 60% of women. 
Studies show that men are more likely than women to start 
treatment late, to interrupt treatment and to be lost to treatment 
follow-up" [13]. 
  
In as much as we believe that this assertion was based on available 
data, our experience in the field is slightly different as more females 
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were willing to be tested, but unpublished reports and discussions 
with participants, males are more likely to honestly discuss their 
sexual habits (even when they have multiple sexual partners), 
commence treatment and stay on treatment [12]. Our field 
experience supports this to an extent. For instance, data from our 
six years work in Nigeria shows that between 2011/12-2016/17, 
close to a million people were tested for HIV across our supported 
service delivery points (Table 3). Over 61% of all those tested 
(539,313) were females. Further review of the report showed that 
females were more likely to be positive with HIV (3.5% vs. 2.2%) 
and less likely to be enrolled into treatment (48.4% vs. 54.3%). 
This report shows that, although less men were tested, a higher 
proportion of males who were HIV positive actually enrolled into 
treatment than their female counterpart. Also, by 2016/17, a slightly 
higher percentage of positive males (3225/4177; 77.2%) were 
currently on treatment as compared to 74.5% (7005/9404) positive 
females. This difference in parameters calls for further investigation 
to identify the factors responsible for this [12]. People in this 
Nigerian population are aware of HIV and AIDS [6, 7]. Apart from 
sexual transmission, many people are still living in ignorance of the 
other means of transmitting HIV as some participants felt that since 
they were not involved in indiscriminate sex, they could not contract 
the virus. There are also those who are not willing to go for a test to 
know their status, preferring to live in ignorance than find out what 
their status is. This was evidenced in the apprehension of some 
people who came for testing. Most public outreach approaches may 
be reaching some of the same set of people who are tested and 
retested at various times. This group of people may have fully 
accepted the concept of routine HIV testing. However proper and 
structured sensitization/awareness coupled with strategic testing 
may be needed to reach those in hard to reach communities. 
  
Limitations: Each team was given 100 rapid test kits which was 
inadequate in one location, but sufficient for the others. Proper 
allocation of consumables will result in better programming. Only 
male condoms were distributed and many people expressed a desire 
for female condoms. It was more difficult to convince people to test 
once the condom supply was exhausted as they incentivised testing. 
Finally, inadequate on ground mobilization prior to the WAD may 
have affected enrolment in some testing locations. Also, the small 
sample size and convenience sampling technique limits the 
generalisation of these findings as it many not be a true 
representation of the actual prevalence of HIV in FCT, Abuja, 
Nigeria. It only suggest that the prevalence of HIV might be lower 
than the reported national average. 
  
  
Conclusion 
 
While community-based testing has consistently had lower positivity 
rate when compared with facility based testing (less than 1% vs 3% 
in this study), national programming is primarily based on facility-
based data such as the sentinel studies using antenatal women. We 
believe that the use of such data-irrespective of how it was modified 
to accommodate the non-sexually active population, may be 
artificially swelling the HIV prevalence rates in Nigeria. This again, 
justifies the need for a population-based study. Despite the 
limitations of this study, our findings reveal that the true prevalence 
of HIV in Nigeria maybe largely unknown as the current figures used 
may not be accurate as the test are done mostly among sexually 
active people. This study questions, therefore, the accuracy of 
current national HIV prevalence as field evidence shows a lot lower 
prevalence rate. There is the need to revisit the national HIV 
prevalence, use aggregate field reports to estimate the true 
prevalence rate, as well as fund, execute and report on a truly 
properly planned community based prevalence study in Nigeria. We 
need to develop and execute this proposed properly planned 
population based study to properly document the true prevalence of 
HIV in Nigeria. However, while working on a formal population 
based study, we can aggregate the various field work reports to get 
an idea what the true prevalence is in Nigeria. 
 
What is known about this topic 
 
 HIV is a major public health challenge with an estimated 
three million plus living with the virus in Nigeria and an 
estimated prevalence rate of 3.0% in 2014; 
 Over the years, the national prevalence is based on 
periodic sentinel surveys using pregnant women and or 
National HIV and AIDS and Reproductive Health Survey. 
 
What this study adds 
 
 This study questions the accuracy of current national HIV 
prevalence as field evidence shows a lot lower prevalence 
rate than what is known from other studies; 
 There is the need to revisit the national HIV prevalence, 
aggregate field reports to estimate the true prevalence 
rate, as well as fund, execute and report on a truly 
properly planned community based prevalence study in 
Nigeria. 
  
  
Competing interests 
 
The authors declare no competing interests. 
  
  
Authors’ contributions 
 
Obinna Ositadimma Oleribe and his team developed, design, 
implemented and evaluated the World AIDS Day program. All 
authors reviewed and finalized the manuscript. All authors read and 
approved the final manuscript. 
  
  
Acknowledgments 
 
Obinna Ositadimma Oleribe acknowledges EFMC for institutional 
support and Institute of Human Virology Nigeria (IHVN) for HIV 
programme funding. SDT-R is grateful to the National Institute for 
Health Research (NIHR) Biomedical Facility at Imperial College 
London for infrastructure support and to the Wellcome Trust ISSF 
for funding (WSGHF28295). 
  
  
Tables and figures 
 
Table 1: Table showing testing frequency per location in Abuja, 
FCT, Nigeria, December 2017  
Table 2: Table showing age and sex disaggregation of those tested 
at the World AIDS Day program, December 2017  
Table 3: Key indicators from a six-year comprehensive HIV 
program in Northern Nigeria: 2011-2017  
Figure 1: Map of Nigeria showing Abuja, the Federal Capital 
Territory (FCT)  
Figure 2: WAD HIV testing and services under a canopy, December 
1, 2017 
  
  
Page number not for citation purposes 4 
References 
 
1. UNAIDS. HIV treatment. Accessed on December 5 2017 
 
2. UNAIDS. 2004 Report on the global epidemic AIDS: 4th global 
report. Joint United Nations Programme on HIV/AIDS 
(UNAIDS). 2004. Google Scholar 
 
3. UNAIDS. AIDS by the numbers: AIDS Is Not Over, But It Can 
Be. Joint United Nations Programme on HIV/AIDS (UNAIDS). 
2016. Google Scholar 
 
4. UNAIDS. Global AIDS Up Date 2016. Joint United Nations 
Programme on HIV/AIDS (UNAIDS). 2016.Google Scholar 
 
5. Federal Ministry of Health [Nigeria]. 2014 National HIV Sero-
prevalence Sentinel Survey among Pregnant Women Attending 
Antenatal Clinics in Nigeria. Published by Department of Public 
Health National AIDS/STI Control Programme, 201 FACT 
SHEET. 2014. Google Scholar 
 
6. Federal Ministry of Health [Nigeria]. National HIV & AIDS and 
Reproductive Health Survey, 2012 (NARHS Plus). Federal 
Ministry of Health Abuja, Nigeria. November 2013. Google 
Scholar 
 
 
 
7. National Population Commission (NPC) [Nigeria] and ICF 
International 2014. Nigeria Demographic and Health Survey 
2013. Abuja, Nigeria, and Rockville, Maryland, USA: NPC and 
ICF International. 2014. 
 
8. UNAIDS. UNAIDS launches 2017 World AIDS Day 
campaign-My Health, My Right. Accessed on December 5 
2017 
 
9. Obinna Ositadimma Oleribe, Grace Iyalla, Ugochinyere Okoro, 
Chidozie Ezechukwu, Emmanuel Agogo, Olabisi Oladipo, John 
Idoko and Simon D Taylor-Robinson. Improving Access to HIV 
and Sexual Reproductive Health Services for Key Populations 
along Nigeria's Transport Corridors: The STOP Project. J AIDS 
Clin Res Sex Transm Dis. 2017; 4: 011. Google Scholar 
 
10. NACA. National Population Based AIDS Indicator Survey 
(NPAIS) Steering Committee Members Inaugurated. 
Accessed on November 12 2017 
 
11. Senator Iroegbu. Nationwide HIV/AIDS Survey, Largest 
Worldwide, Says NACA Boss. Accessed on November 12 
2017. 
 
12. EFMC. Report for comprehensive HIV in Nigeria. In Press. 
 
13. UNAIDS. Press release. Accessed on July 12 2017. 
 
  
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
Table 2: Table showing age and sex disaggregation of those tested at the World AIDS Day program, December 2017 
Age Group Male Female 
 
Tested Positive Tested Positive 
0 – 14 - - - - 
15 – 18 5 - 1 - 
19 – 25 32 - 10 - 
25 – 49 150 - 30 2 
>50 8 - 1 - 
 
195 0 42 2 
 
 
 
 
  
 
 
 
 
 
 
 
 
Table 1: Table showing testing frequency per location in Abuja, FCT, Nigeria, December 2017 
Location Male Females Total 
Galadimma 77 77% 23 23% 100 42% 
EFMC Office 27 93% 2 7% 29 12% 
Dutse-Alhaji Junction 42 81% 10 19% 52 22% 
Efab Estate - Dutse 49 88% 7 13% 56 24% 
Total 195 82% 42 18% 237 100% 
Table 3: Key indicators from a six-year comprehensive HIV program in Northern Nigeria: 2011 -2017 
Indicators Male Female Total 
HTC tested 356,319 (38.95) 558,739 (61.1%) 915,058 (100%) 
HTC positive 7,695 (2.2%) 19,426 (3.5%) 27,121(3.0%) 
HTC negative 348,624 (97.8%) 539,313 (6.5%) 887,937 (97.0%) 
New on treatment/Treatment 
enrolment rate 
4,177 (54.3%) 9,404 (48.4%) 13,581 (50.1%) 
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Figure 1: Map of Nigeria showing Abuja, the Federal Capital Territory (FCT)  
 
 
 
 
Figure 2: WAD HIV testing and services under a canopy, December 1, 2017 
 
